McWilliams David
CIK: 0001303311
Primary company: Opexa Therapeutics, Inc. (opxa)
McWilliams David is a corporate insider at Opexa Therapeutics, Inc. (opxa) filing SEC Form 4 transactions. 45 transactions across 2 companies, totaling $44,868 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 61,984 | - | - | 123,968 | 12/24/2024 Filed: 12/27/2024 | Filing → | |
| Award | 61,984 | $0.00 | $0 | 61,984 | 6/22/2022 Filed: 6/24/2022 | Filing → | |
| Purchase | 200 | $27.56 | $6K | 620,301 | 12/14/2021 Filed: 12/16/2021 | Filing → | |
| Purchase | 1,500 | $5.40 | $8K | 620,101 | 11/20/2020 Filed: 11/24/2020 | Filing → | |
| Exercise | 1,054 | $0.00 | $0 | 0 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| J | 1,054 | $0.00 | $0 | 1,054 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 6,555 | $0.00 | $0 | 0 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 3,746 | $0.00 | $0 | 0 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 7,663 | $0.00 | $0 | 0 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 152,604 | $0.00 | $0 | 0 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 7,609 | - | - | 618,601 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 3,746 | - | - | 610,992 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 7,663 | - | - | 607,246 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Exercise | 152,604 | - | - | 599,583 | 9/29/2020 Filed: 9/30/2020 | Filing → | |
| Purchase | 2,608 | $5.75 | $15K | 446,979 | 9/29/2020 Filed: 9/29/2020 | Filing → | |
Opexa Therapeutics, Inc. opxa | Award | 8,000 | - | - | 246,668 | 8/26/2009 Filed: 8/27/2009 | Filing → |
Opexa Therapeutics, Inc. opxa | J | 37,000 | - | - | 238,668 | 8/23/2009 Filed: 8/27/2009 | Filing → |
Opexa Therapeutics, Inc. opxa | Award | 8,000 | - | - | 275,668 | 2/6/2009 Filed: 2/9/2009 | Filing → |
Opexa Therapeutics, Inc. opxa | Award | 39,000 | - | - | 267,668 | 6/26/2008 Filed: 6/30/2008 | Filing → |
Opexa Therapeutics, Inc. opxa | Award | 10,000 | - | - | 228,668 | 6/26/2008 Filed: 6/30/2008 | Filing → |
Type
Award
Shares
61,984
Price
-
Value
-
Type
Award
Shares
61,984
Price
$0.00
Value
$0
Type
Purchase
Shares
200
Price
$27.56
Value
$6K
Type
Purchase
Shares
1,500
Price
$5.40
Value
$8K
Type
Exercise
Shares
1,054
Price
$0.00
Value
$0
Type
J
Shares
1,054
Price
$0.00
Value
$0
Type
Exercise
Shares
6,555
Price
$0.00
Value
$0
Type
Exercise
Shares
3,746
Price
$0.00
Value
$0
Type
Exercise
Shares
7,663
Price
$0.00
Value
$0
Type
Exercise
Shares
152,604
Price
$0.00
Value
$0
Type
Exercise
Shares
7,609
Price
-
Value
-
Type
Exercise
Shares
3,746
Price
-
Value
-
Type
Exercise
Shares
7,663
Price
-
Value
-
Type
Exercise
Shares
152,604
Price
-
Value
-
Type
Purchase
Shares
2,608
Price
$5.75
Value
$15K
Opexa Therapeutics, Inc.
opxa
Type
Award
Shares
8,000
Price
-
Value
-
Opexa Therapeutics, Inc.
opxa
Type
J
Shares
37,000
Price
-
Value
-
Opexa Therapeutics, Inc.
opxa
Type
Award
Shares
8,000
Price
-
Value
-
Opexa Therapeutics, Inc.
opxa
Type
Award
Shares
39,000
Price
-
Value
-
Opexa Therapeutics, Inc.
opxa
Type
Award
Shares
10,000
Price
-
Value
-
AI Agent
Try asking...